Sp626
THE RIPPLE EFFECT: HOW COVID-19 HAS IMPACTED EQUITY AND OPPORTUNITY
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinical and research practices; and 3) to examine structural barriers in the field of gastroenterology during the pandemic and effective advocacy strategies.
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinical and research practices; and 3) to examine structural barriers in the field of gastroenterology during the pandemic and effective advocacy strategies.
Presenter
Tracks
Related Products
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PERSONALIZED ENDOSCOPY: ERGONOMICS AND THE ENDOSCOPE
This session will highlight the current state of the art around innovation in endoscopy as it pertains to climate, the environment, and the endoscopist…
INTRODUCTION
SOCIETY: AGA
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
